Corresponding human studies have been conducted mostly in patients with T2DM [17], metabolic syndrome [18], [19], coronary heart disease [18], osteoporosis therapy [20] or hypertension [19], and these have witnessed low osteocalcin to associate with higher fasting plasma insulin, glucose and triglyceride levels without proof of causality. The gene discussed is INS; the disease is osteoporosis.